.Pharmacolibrary.Drugs.N_NervousSystem.N06A_Antidepressants.N06AB07_Alaproclate.Alaproclate .Pharmacolibrary.Drugs.N_NervousSystem.N06A_Antidepressants.N06AB07_Alaproclate.Alaproclate| name: | Alaproclate | |
| ATC code: | N06AB07 | |
| route: | oral | |
| compartments: | 1 | |
| dosage: | 100 | mg |
| volume of distribution: | 150 | L |
| clearance: | 10 | L/h |
| other parameters in model implementation | ||
Alaproclate is a selective serotonin reuptake inhibitor (SSRI) that was primarily investigated as an antidepressant in the 1970s and 1980s. It is not currently approved for clinical use and is not used in medical practice today.
Estimated pharmacokinetic parameters for adult population (sex and comorbidities unspecified), as no direct published sources reporting precise human pharmacokinetics were found.